Kilts to oversee Gillette/P&G integration
This article was originally published in The Tan Sheet
Executive SummaryGillette CEO James Kilts is stepping down as head of the blades and razors business effective July 1, P&G reports May 24. However, because "there is still a lot of work to do" regarding the Gillette integration, Kilts will continue with the company as vice chairman of P&G's board of directors until Oct. 1, a P&G spokesperson said. "Last year we planned the integration and the deal closed Oct. 1, so we're only about six months into the integration," he said. "There's still much more work ahead and [Kilts] will focus exclusively on that." P&G acquired Gillette Oral Care last year in a $57 bil. transaction (1"The Tan Sheet" Oct. 10, 2005, p. 13). Kilts will retire upon the Oct. 1 culmination of his duties, the firm noted; until then, he will continue reporting to President and CEO A.G. Lafley. The exec will be replaced by current President-Global Duracell & Braun Mark Leckie, who will assume his new position as group president-Gillette global business in July. Leckie will take on Kilts' day-to-day responsibilities, according to the firm...
You may also be interested in...
Keeping Track: US FDA's Rejection Of First RMAT BLA Blemishes Otherwise Positive Week Of Non-Oncology News
The latest non-oncology drug development news and highlights from our US FDA Performance Tracker.
Stephen Hahn, the Trump administration’s nominee to lead the US FDA, has been approved by the Senate Health, Education, Labor and Pensions (HELP) Committee, with some “no votes” from Democratic senators in leadership positions, and is expected to be considered by the full Senate this week.